Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;34(2):417-425.
doi: 10.1038/s41379-020-00671-z. Epub 2020 Sep 18.

Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning

Affiliations

Prediction of early recurrence of hepatocellular carcinoma after resection using digital pathology images assessed by machine learning

Akira Saito et al. Mod Pathol. 2021 Feb.

Abstract

Hepatocellular carcinoma (HCC) is a representative primary liver cancer caused by long-term and repetitive liver injury. Surgical resection is generally selected as the radical cure treatment. Because the early recurrence of HCC after resection is associated with low overall survival, the prediction of recurrence after resection is clinically important. However, the pathological characteristics of the early recurrence of HCC have not yet been elucidated. We attempted to predict the early recurrence of HCC after resection based on digital pathologic images of hematoxylin and eosin-stained specimens and machine learning applying a support vector machine (SVM). The 158 HCC patients meeting the Milan criteria who underwent surgical resection were included in this study. The patients were categorized into three groups: Group I, patients with HCC recurrence within 1 year after resection (16 for training and 23 for test); Group II, patients with HCC recurrence between 1 and 2 years after resection (22 and 28); and Group III, patients with no HCC recurrence within 4 years after resection (31 and 38). The SVM-based prediction method separated the three groups with 89.9% (80/89) accuracy. Prediction of Groups I was consistent for all cases, while Group II was predicted to be Group III in one case, and Group III was predicted to be Group II in 8 cases. The use of digital pathology and machine learning could be used for highly accurate prediction of HCC recurrence after surgical resection, especially that for early recurrence. Currently, in most cases after HCC resection, regular blood tests and diagnostic imaging are used for follow-up observation; however, the use of digital pathology coupled with machine learning offers potential as a method for objective postoprative follow-up observation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Image analysis process.
Whole slide image (WSI) scans of hepatocellular carcinoma (HCC) and surrounding non-HCC area (a), region of interest (ROI) selection for HCC (b), and non-HCC (f), nuclei selection by Ilastik for HCC (c) and non-HCC (g), mask image for HCC (d) and non-HCC (h), and analysis images for HCC (e) and non-HCC (i).
Fig. 2
Fig. 2. Algorithm for prediction using three support vector machine (SVM) models.
The average values of the probabilities predicted to be Groups I, II, and III in the region of interest (ROI) of the HCC area were set as A, B, and C, respectively, whereas the average values of the probabilities predicted to be Groups I, II, and III in the ROI in the non-HCC area were set as D, E, and F, respectively. The predicted probability of a nucleus belonging to Group I was set as G.

References

    1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76. doi: 10.1053/j.gastro.2007.04.061. - DOI - PubMed
    1. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–35. doi: 10.1097/01.sla.0000197706.21803.a1. - DOI - PMC - PubMed
    1. Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, et al. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes. Surgery. 2007;141:330–9. doi: 10.1016/j.surg.2006.06.028. - DOI - PubMed
    1. Sherman M. Recurrence of hepatocellular carcinoma. N Engl J Med. 2008;359:2045–7. doi: 10.1056/NEJMe0807581. - DOI - PubMed
    1. Shimada M, Takenaka K, Gion T, Fujiwara Y, Kajiyama K, Maeda T, et al. Prognosis of recurrent hepatocellular carcinoma: a 10-year surgical experience in Japan. Gastroenterology. 1996;111:720–6. doi: 10.1053/gast.1996.v111.pm8780578. - DOI - PubMed